saved
Need
Status: Need is Closed

What would enable more patients to take part in clinical trials

Request Number

NG_2017_0002_N_007
Point of Contact
Need was closed on
May 21
Description

Clinical trials are required whenever GSK develops a new medicine. Patients are central to any clinical trial and every new medicine that GSK works on – we are always looking at ways in which GSK can improve the access to clinical trials so that eligible patients who wish to are able to participate.

 

 

Background

Estimates vary but an often-quoted metric is that only 3%-5% of eligible patients participate in clinical trials. The reasons for this low number vary from geographical barriers to participation, to the need for patients to take time out from their lives to travel to the relevant hospitals for regular visits, to a lack of awareness of clinical trials as an option for patients to take part in. GSK are looking for novel ways to enable eligible patients to participate in clinical trials and remove the things that prevent them from doing so.

 

Successful applicants with viable proposals with sufficient experience in the clinic will be invited to present their proposal to a group within GSK. Subsequently, if the idea is sufficiently mature with experience in clinical, there may be opportunities to scope a prototype within GSK and even to pilot the innovation within a GSK clinical study.

Key success Criteria
  • Approaches that increase the number of eligible patients that choose to participate in clinical trials
  • The ideas should be compatible with Good Clinical Practice and other regulatory and legal requirements for clinical research 

 

Approaches not of Interest
  • Digital Marketing technologies such as Pay-per-click or Facebook advertising, traditional media promotion activities 

 

Due Date
Apr 8
Items to be submitted
  • A non-confidential proposal describing the solution and how the success criteria will be met with the proposed solution
  • non-confidential description of the technology
  • An overview of your experience with digital tools and/or clinical trials

 

Client Point of Contact

Martin Wallace
Gallery Moderator(s)
Stephen Clulow
Request Number
NG_2017_0002_N_007
Preferred Collaboration Types
Area of Interest